Amphastar Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Amphastar Pharmaceuticals,

01/03/2023 05:07

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 73 cents​​ per share for the quarter ended
in December. The mean expectation of six analysts for the
quarter was for earnings of 41 cents per share.
    * Revenue rose 11.7% to $135.02 million from a year ago;
analysts
expected $126.98 million. 
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Amphastar Pharmaceuticals Inc shares had risen by 13.7%
this
quarter.
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $37.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 1
at 05:07 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.41           0.73           Beat
 Sep. 30 2022      0.39           0.38           Missed
 Jun. 30 2022      0.35           0.39           Beat
 Mar. 31 2022      0.36           0.47           Beat